Earnings Per Share (Schedule of Basic and Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income		$ 235	$ 171	$ 71
Weighted-average common shares outstanding		77,000,000	80,500,000	81,800,000
Weighted-average common shares outstanding - assuming dilution		78,000,000	80,900,000	82,000,000
Basic earnings per share (in dollars per share)		$ 3.05	$ 2.13	$ 0.87
Diluted earnings per share (in dollars per share)		$ 3.01	$ 2.12	$ 0.87
Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of dilutive securities	[1]	600,000	300,000	100,000
Antidilutive securities excluded from computation of diluted earnings per share (in shares)		384,580	507,005	769,704
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of dilutive securities	[2]	200,000	0	0
Antidilutive securities excluded from computation of diluted earnings per share (in shares)		657,029	1,276,776	1,357,963
Performance Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of dilutive securities	[3]	200,000	0	0
Antidilutive securities excluded from computation of diluted earnings per share (in shares)		0	646,230	159,769

[1] RSUs of 384,580 shares, 507,005 shares and 769,704 shares for the years ended December 31, 2024, 2023 and 2022, respectively, were not included in the diluted earnings per share calculation because their effect would have been anti-dilutive.

[2] Stock options to purchase 657,029 shares, 1,276,776 shares and 1,357,963 shares for the years ended December 31, 2024, 2023 and 2022, respectively, were not included in the diluted earnings per share calculation because their effect would have been anti-dilutive.

[3] Performance options to purchase 646,230 shares and 159,769 shares for the years ended December 31, 2023 and 2022, respectively, were not included in the diluted earnings per share calculation because their effect would have been anti-dilutive. There were no anti-dilutive performance options for the year ended December 31, 2024.